ENTITY

Biomarin Pharmaceutical (BMRN US)

58
Analysis
Health CareUnited States
BioMarin Pharmaceutical Inc. develops and commercializes therapeutic enzyme products. The Company has applied its proprietary enzyme technology to develop products for lysosomal storage diseases and for the treatment of serious burns. BioMarin's subsidiary provides analytical and diagnostic products and services in the area of carbohydrate biology.
more
Refresh
Company Presentation25 Apr 2024 04:30
Company Presentation23 Feb 2024 05:30
Company Presentation02 Nov 2023 04:30
Company Presentation12 Sep 2023 20:00
Company Presentation01 Dec 2021 00:00
x